GLP-1 medication's effect on nerve damage in type 2 diabetes
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests whether a GLP-1 medication (a type of diabetes drug) can help protect nerves in the heart from damage caused by diabetes. If you have type 2 diabetes and are overweight, this trial might help researchers understand if this medication improves how your heart's nervous system works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18–70 years old
- You have been diagnosed with type 2 diabetes
- You are overweight or obese (BMI of 24 or higher)
- You are not pregnant or breastfeeding
- You do not have pancreas inflammation (pancreatitis) or recent severe diabetes emergencies
- You do not have heart rhythm problems, thyroid disease, or serious organ damage
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a type of diabetes medicine called GLP-1RA can help prevent or improve nerve damage in the heart caused by diabetes. It is for people with type 2 diabetes who are overweight or obese.
This trial tests how a new type of diabetes medicine, called a GLP-1 receptor agonist, affects heart artery health in people with type 2 diabetes who recently had a heart procedure. It aims to find out if adding this medicine can further protect the heart and improve recovery.
This study uses a special full-body PET scan to see how two natural hormones, GIP and GLP-1, affect how your body uses sugar and moves blood. It includes healthy volunteers and people with type 2 diabetes who are on metformin only.
This study tests whether a GLP-1 receptor agonist (a type of diabetes medicine) changes how the brain responds to insulin in people with different body sizes. It may help understand if this drug can improve brain function related to insulin.
This trial tests a new GLP-1 receptor agonist to improve blood sugar control in people with type 2 diabetes. It may be an option if you haven't used a similar drug in the last three months and your medical records are complete.
This study tests whether diabetes medicines can help prevent worsening heart and kidney problems in people with type 2 diabetes. You’ll be assigned by chance to one of these medicine types, and your other care will be adjusted for safety.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.